Correlation Between Eliem Therapeutics and Cingulate Warrants
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Cingulate Warrants, you can compare the effects of market volatilities on Eliem Therapeutics and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Cingulate Warrants.
Diversification Opportunities for Eliem Therapeutics and Cingulate Warrants
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eliem and Cingulate is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Cingulate Warrants go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Cingulate Warrants
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 103.22 times less return on investment than Cingulate Warrants. But when comparing it to its historical volatility, Eliem Therapeutics is 18.1 times less risky than Cingulate Warrants. It trades about 0.02 of its potential returns per unit of risk. Cingulate Warrants is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 7.99 in Cingulate Warrants on August 27, 2024 and sell it today you would lose (3.86) from holding Cingulate Warrants or give up 48.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 76.02% |
| Values | Daily Returns |
Eliem Therapeutics vs. Cingulate Warrants
Performance |
| Timeline |
| Eliem Therapeutics |
| Cingulate Warrants |
Eliem Therapeutics and Cingulate Warrants Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Cingulate Warrants
The main advantage of trading using opposite Eliem Therapeutics and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Cingulate Warrants vs. Eliem Therapeutics | Cingulate Warrants vs. HCW Biologics | Cingulate Warrants vs. Scpharmaceuticals | Cingulate Warrants vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |